Search

Author/Creator Labourey, Jean-Luc

1. Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial. Issue 7 (July 2015)

Authors:
Fizazi, Karim; Faivre, Laura; Lesaunier, François; Delva, Remy; Gravis, Gwenaëlle; Rolland, Frédéric; Priou, Frank; Ferrero, Jean-Marc; Houede, Nadine; Mourey, Loïc; Theodore, Christine; Krakowski, Ivan; Berdah, Jean-François; Baciuchka, Marjorie; Laguerre, Brigitte; Fléchon, Aude; Ravaud, Alain;...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 7(2015:Jul.)
Page Start:
787
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Effectiveness and safety of nivolumab in the treatment of lung cancer patients in France: preliminary results from the real-world EVIDENS study. (1st January 2020)

Authors:
Barlesi, Fabrice; Dixmier, Adrien; Debieuvre, Didier; Raspaud, Christophe; Auliac, Jean-Bernard; Benoit, Nicolas; Bombaron, Pierre; Moro-Sibilot, Denis; Audigier-Valette, Clarisse; Asselain, Bernard; Egenod, Thomas; Rabeau, Audrey; Fayette, Jérôme; Sanchez, Myriam Locatelli; Labourey, Jean-Luc; W...
Journal:
Oncoimmunology
Issue:
Volume 9:Number 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search